Search results
The growing promise of cancer vaccines
Cosmos· 4 days agoA cure for cancer — which is second only to cardiovascular diseases in its contribution to the global burden of disease — has long been a dream. While no magic bullet is yet in sight, three ...
Research identifies an infectious language epidemic
Digital Journal· 4 days agoWhat effects did social media rhetoric have on COVID-19 infection and death rates across the U.S., and what can policymakers and public health officials...
New approach uses 'cloaked' proteins to deliver cancer-killing therapeutics into cells
Phys.org· 1 day agoThe generalizable technique could lead to repurposing thousands of commercial protein products, including antibodies, for biological research and therapeutic applications. The group's paper, ...
Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In...
Benzinga· 3 days agoAre they in your portfolio? First Solar, Inc. FSLR shares jumped 41.5% possibly in response to...
Explainer-What are the FLiRT COVID variants and are they more contagious? By Reuters
Investing.com· 5 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
mRNA Vaccines vs. the Pandemic
The North Coast Journal· 7 days ago"I knew that [mRNA] can be used for everything and I had a kind of a Cassandra feeling, that I can see the future and nobody believes me." About 13...
‘Cloaked’ proteins deliver cancer-killing therapeutics into cells | Cornell Chronicle
Cornell News Service· 2 days agoAn interdisciplinary collaboration has designed a way to “cloak” proteins so that they can be...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks· 7 days agoFree Report) and Pfizer (PFE Quick QuotePFE - Free Report) to set up a possible vaccine program aimed at preventing the spread of the H5N1 virus, also known as bird flu, in humans. Both these ...
The Heroes Of Vaccine Development: Lipid Nanoparticles
BioresearchOnline· 3 days agoLipid nanoparticles (LNPs) have played a crucial role in the advancement of vaccine development,...
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology...
Benzinga· 2 days agoPlanegg/Martinsried, May 28, 2024 – Medigene AG (Medigene or the "Company", FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid